Objectively, it is possible that Leu56Met represents a frequent pathogenic variant with very low penetrance, thus conveying a low lifetime risk of developing MTC, as recently reported for the pathogenic RET variant p.Val804Met (24). The gene discussed is RET; the disease is medullary thyroid gland carcinoma.